JHSPersonal Care
JHS Svendgaard Laboratories Ltd — Cash Flow Statement
₹6.55
-4.15%
JHS Svendgaard Laboratories Ltd Cash Flow Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Free Cash Flow | -15.71 Cr | -40.12 Cr | 8.94 Cr | -15.87 Cr | — |
| Issuance Of Capital Stock | 22.50 Cr | — | 0.00 | -0.25 Cr | 11.75 Cr |
| Capital Expenditure | -10.53 Cr | -31.53 Cr | -14.34 Cr | -6.74 Cr | — |
| End Cash Position | 6.75 Cr | 9.10 Cr | 37.51 Cr | 5.29 Cr | — |
| Beginning Cash Position | 9.10 Cr | 37.25 Cr | 5.19 Cr | 20.79 Cr | — |
| Changes In Cash | -2.36 Cr | -28.14 Cr | 32.06 Cr | -15.50 Cr | — |
| Financing Cash Flow | 23.07 Cr | 2.17 Cr | -0.90 Cr | -1.67 Cr | — |
| Interest Paid Cff | -0.23 Cr | -0.41 Cr | -0.24 Cr | -1.01 Cr | — |
| Net Common Stock Issuance | 22.50 Cr | — | 0.00 | -0.25 Cr | 11.75 Cr |
| Common Stock Issuance | 22.50 Cr | — | 0.00 | -0.25 Cr | 11.75 Cr |
| Net Issuance Payments Of Debt | 1.58 Cr | 3.18 Cr | -0.21 Cr | 0.29 Cr | — |
| Net Short Term Debt Issuance | 1.02 Cr | 3.30 Cr | -0.06 Cr | 0.28 Cr | — |
| Net Long Term Debt Issuance | 0.57 Cr | -0.12 Cr | -0.14 Cr | 0.01 Cr | — |
| Investing Cash Flow | -20.25 Cr | -21.73 Cr | 9.68 Cr | -4.70 Cr | — |
| Net Other Investing Changes | -13.76 Cr | 1.67 Cr | 1.14 Cr | -0.37 Cr | — |
| Interest Received Cfi | 1.77 Cr | 0.56 Cr | 0.99 Cr | 2.48 Cr | — |
| Net Investment Purchase And Sale | 0.17 Cr | -0.30 Cr | -0.72 Cr | -0.40 Cr | — |
| Sale Of Investment | 0.17 Cr | — | 0.31 Cr | 0.00 | 19.93 Cr |
| Purchase Of Investment | 0.00 | -0.30 Cr | -0.72 Cr | -0.40 Cr | — |
| Net PPE Purchase And Sale | -9.25 Cr | -23.73 Cr | -2.59 Cr | -6.40 Cr | — |
| Sale Of PPE | 1.28 Cr | 7.81 Cr | 11.76 Cr | 0.34 Cr | — |
| Purchase Of PPE | -10.53 Cr | -31.53 Cr | -14.34 Cr | -6.74 Cr | — |
| Operating Cash Flow | -5.18 Cr | -8.58 Cr | 23.29 Cr | -9.14 Cr | — |
| Taxes Refund Paid | -0.28 Cr | 0.00 | 0.00 | -0.31 Cr | — |
| Change In Working Capital | -4.26 Cr | -10.88 Cr | 23.65 Cr | -9.11 Cr | — |
| Change In Other Current Liabilities | 0.11 Cr | -13.23 Cr | 12.18 Cr | -13.92 Cr | — |
| Change In Other Current Assets | -2.28 Cr | 4.44 Cr | 4.00 Cr | -22.37 Cr | — |
| Change In Payable | -0.39 Cr | -8.11 Cr | 10.10 Cr | -3.39 Cr | — |
| Change In Inventory | 0.77 Cr | 0.35 Cr | -1.25 Cr | -0.72 Cr | — |
| Change In Receivables | -2.44 Cr | 5.56 Cr | -1.11 Cr | 30.96 Cr | — |
| Other Non Cash Items | 1.70 Cr | -0.32 Cr | -0.84 Cr | -5.93 Cr | — |
| Provisionand Write Offof Assets | 1.31 Cr | -0.52 Cr | 18.36 Cr | -0.49 Cr | — |
| Depreciation And Amortization | 7.95 Cr | 6.35 Cr | 6.02 Cr | 7.05 Cr | — |
| Depreciation | 7.95 Cr | 6.21 Cr | 6.00 Cr | 6.33 Cr | — |
| Pension And Employee Benefit Expense | 0.21 Cr | — | — | — | — |
| Gain Loss On Investment Securities | -0.05 Cr | — | -0.04 Cr | 0.03 Cr | 0.10 Cr |
| Net Foreign Currency Exchange Gain Loss | -41000.00 | -1000.00 | -0.90 Cr | -0.65 Cr | — |
| Gain Loss On Sale Of PPE | -0.06 Cr | -15000.00 | -0.04 Cr | 0.00 | — |
| Net Income From Continuing Operations | -12.51 Cr | -3.43 Cr | -22.95 Cr | 0.10 Cr | — |
| Other Cash Adjustment Outside Changein Cash | — | -1000.00 | 0.26 Cr | — | — |
| Net Other Financing Charges | — | -1000.00 | — | — | 54000.00 |
| Amortization Cash Flow | — | 0.13 Cr | 0.01 Cr | 0.72 Cr | 0.02 Cr |
| Net Business Purchase And Sale | — | — | — | — | 0.00 |
| Purchase Of Business | — | — | — | — | 0.00 |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on JHS Svendgaard Laboratories Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.